Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference5 articles.
1. Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial;Gessner;Vaccine,2019
2. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial;Maruyama;BMJ,2010
3. Suzuki M, Morimoto K, Parry CM, Ariyoshi K. Concerns about the PPV23 trial in Japan. 2016. Available from: https://www.bmj.com/content/340/bmj.c1004/rr
4. Accuracy of composite diagnostic standards for pneumococcal pneumonia in vaccine trials;Suzuki;Epidemiol Infect,2018
5. Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study;Suzuki;Lancet Infect Dis,2017
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献